Jianyou Co., Ltd. (603707.SH) subsidiary obtains U.S. FDA approval for transfer of production site of Depobupivacaine injection.

Wisdom Financial APP News, Jianyou Co., Ltd. (603707.SH) announced that its subsidiary Meitheal Pharmaceuticals, Inc. ("Meitheal") recently received approval from the U.S. Food and Drug Administration (FDA) for the transfer of production site of Etoposide Injection, 100 mg/5 mL, 500 mg/25 mL, and 1 g/50 mL, multiple doses (ANDA number: 074529), and approved for production at the production site of the company's subsidiary Jianjin Pharmaceutical Co., Ltd.